Effects of endomorphin-1 on open-field behavior and on the hypothalamic-pituitary-adrenal system

被引:17
作者
Bujdosó, E
Jászberényi, M
Tömböly, C
Tóth, G
Telegdy, G
机构
[1] Univ Szeged, MTA Neurohumoral Res Grp, Albert Szent Gyorgyi Med & Pharmaceut Ctr, Dept Pathophysiol, H-6701 Szeged, Hungary
[2] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary
基金
匈牙利科学研究基金会;
关键词
endomorphin-1; open-field behavior; hypothalamic-pituitary-adrenal axis;
D O I
10.1385/ENDO:14:2:221
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effects of endomorphin-1 (EM1) on behavioral responses and on the hypothalamic-pituitary-adrenal system were investigated in mice. Locomotor activity was measured in an "open-field" apparatus, with parallel recording of the numbers of rearings and groomings, Different doses of the peptide (250 ng to 5 mug) were administered to the animals intracerebroventricularly 30 min before the tests. EM1 caused significant increases in the locomotor activity and the number of rearings, The effect of EM1 on the basal corticosterone secretion was also investigated. At a dose of 5 mug, the peptide significantly increased plasma corticosterone level. The corticotropin-releasing hormone (CRH) antagonist alpha -helical CRH9-41 applied 30 min prior to EM1 administration, completely abolished the increases in both locomotion and the number of rearings and attenuated the corticosterone release evoked by EM1,These results suggest that the EM1-induced increases in locomotion and rearing activity as well as the pituitaryadrenal activation are mediated by CRH.
引用
收藏
页码:221 / 224
页数:4
相关论文
共 40 条
[1]   ENDOGENOUS OPIOIDS - BIOLOGY AND FUNCTION [J].
AKIL, H ;
WATSON, SJ ;
YOUNG, E ;
LEWIS, ME ;
KHACHATURIAN, H ;
WALKER, JM .
ANNUAL REVIEW OF NEUROSCIENCE, 1984, 7 :223-255
[2]   Endomorphins have orexigenic and anxiolytic activities in mice [J].
Asakawa, A ;
Inui, A ;
Momose, K ;
Ueno, N ;
Fujino, MA ;
Kasuga, M .
NEUROREPORT, 1998, 9 (10) :2265-2267
[3]   TIME-DOSE RELATIONSHIPS FOR LOCOMOTOR ACTIVITY EFFECTS OF MORPHINE AFTER ACUTE OR REPEATED TREATMENT [J].
BABBINI, M ;
DAVIS, WM .
BRITISH JOURNAL OF PHARMACOLOGY, 1972, 46 (02) :213-&
[4]  
Becker C, 1999, SYNAPSE, V34, P47, DOI 10.1002/(SICI)1098-2396(199910)34:1<47::AID-SYN6>3.0.CO
[5]  
2-9
[6]   Specific G protein activation and μ-opioid receptor internalization caused by morphine, DAMGO and endomorphin I [J].
Burford, NT ;
Tolbert, LM ;
Sadee, W .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 342 (01) :123-126
[7]   Endomorphin 1 and 2, endogenous ligands for the mu-opioid receptor, decrease cardiac output, and total peripheral resistance in the rat [J].
Champion, HC ;
Zadina, JE ;
Kastin, AJ ;
Hackler, L ;
Ge, LJ ;
Kadowitz, PJ .
PEPTIDES, 1997, 18 (09) :1393-1397
[8]   DIFFERENTIAL CARDIOVASCULAR EFFECTS OF MU-OPIATE, DELTA-OPIATE AND KAPA-OPIATE AGONISTS AT DISCRETE HYPOTHALAMIC SITES IN THE ANESTHETIZED RAT [J].
FEUERSTEIN, G ;
FADEN, AI .
LIFE SCIENCES, 1982, 31 (20-2) :2197-2200
[9]   EFFECTS OF OPIATE RECEPTOR AGONISTS AND ANTAGONISTS ON THE STRESS-INDUCED SECRETION OF CORTICOSTERONE IN MICE [J].
GIBSON, A ;
GINSBURG, M ;
HALL, M ;
HART, SL .
BRITISH JOURNAL OF PHARMACOLOGY, 1979, 65 (01) :139-146
[10]  
Goldberg IE, 1998, J PHARMACOL EXP THER, V286, P1007